Langerhans' cell histiocytosis: Current trends and the role of the head and neck surgeon

16Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Langerhans' cell histiocytosis (LCH)-once called histiocytosis X-is a complex reticuloendothelial disease that often involves the head and neck. We discuss the current nomenclature of this disease and review its pathologic and clinical characteristics, with particular emphasis on the role of the head and neck surgeon. LCH can be challenging to diagnose, and the otolaryngologist must be familiar with its varied presentations. Because LCH usually responds well to medical therapy and extensive resection can easily cause more morbidity than the disease itself, a minimalist approach to treatment usually provides the best outcome. We also discuss the case of a 9-month-old girl with LCH who presented with aggressive head and neck disease.

Cite

CITATION STYLE

APA

Davis, S. E., & Rice, D. H. (2004). Langerhans’ cell histiocytosis: Current trends and the role of the head and neck surgeon. Ear, Nose and Throat Journal. Medquest Communications LLC. https://doi.org/10.1177/014556130408300515

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free